Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Merit Medical snags EN Snare

This article was originally published in The Gray Sheet

Executive Summary

Foreign body retrieval device is acquired from medical technology incubator Hatch Medical for $21 million. Cleared via 510(k) in 2002, the endovascular snare is used for retrieval and removal of stents, vena cava filters and embolic coils, as well as the manipulation of abdominal aortic aneurysm stent grafts, Merit Medical says. The device generates worldwide sales of about $6 million. Merit, which makes disposable interventional and diagnostic devices, will pay $14 million up-front for EN Snare, with an additional $7 million contingent upon completion of certain milestones. While EN Snare marks Merit's entry into the snare market, the firm "intends to offer additional snare products for gastroenterology and cardiology in the future," Merit says. "Overall, we believe the combined market opportunities for snare products exceed $125 million.
Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT027531

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel